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ABSTRACT 
Abdominal visceral adiposity (VAT) has been shown 
to be an independent risk factor for metabolic and 
cardiovascular disease. Using enCORE analysis 
version 13.6 on a GE Lunar iDXA, a new fully 
automated analysis software to measure VAT, we 
determined the strength of associations between 
DEXA-derived VAT and other known indicators for 
diabetes and cardiovascular disease risk in 
Caucasian and African American obese women. We 
collected anthropometrics, vital signs, lipid profile, 
and DXA whole body composition scan for 229 
subjects with BMI 30.0 – 49.9 kg/m2 & age 21 to 69 
y. We then performed the non-parametric Spearman 
correlation analysis and found that in subjects 
overall, DEXA-VAT is positively associated with 
triglyceride, fasting glucose, fasting insulin, and 
HOMA-IR, and negatively associated with HDL. 
Among all anthropometric, body composition and 
cardiometabolic variables, DEXA-VAT was the most 
robust predictor of impaired glucose tolerance (IGT) 
and metabolic syndrome (MetSx) in binary 
regression analysis, even after adjusting for race. 
LASSO regression after adjusting for covariates that 
best predicted IGT and MetSx showed that HOMA-
IR and DEXA-VAT most significantly predicted IGT 
(p<0.001, p<0.001, respectively), and DEXA-VAT 
most significantly predicted MetSx (p<0.001). These 
observations have implications for VAT associated 
risk in diabetes and cardiovascular disease. 
 
INTRODUCTION 
•  Abdominal obesity, especially the visceral 
component of adipose tissue (VAT), is strongly 
associated with metabolic and cardiovascular risk 
in humans (1-2). 
•  The differences in sex and race with regard to 
body composition and metabolic risk have also 
been demonstrated with VAT associated risk. 
•  Although CT and MRI are considered the “gold 
standards” in the measurement of type and 
distribution of body fat, dual energy X-ray 
absorptiometry (DEXA) can accurately measure 
body composition with high-precision, low X-ray 
exposure, and short-scanning time (3). 
•  We previously showed strong correlations 
between DEXA and MRI whole body composition, 
with coefficients of variation of ≤ 2% for DEXA-
derived adiposity measures (4). 
•  In addition to whole body composition, we now 
have a newly available software to estimate VAT 
area (cm3) and mass (g) using enCORE analysis 
version 13.6 (5) on a GE Lunar iDXA.  
 
METHODS 
Study: Cross-sectional design of subjects 
previously recruited for studies at the Vanderbilt 
Clinical Research Center. 
Subjects: 229 subjects with BMI 30.0 – 49.9 kg/m2 
& age 21 to 69 y. All records de-identified. 
Measures 
Anthropometrics 
Height, weight, BMI, Waist & hip circumference 
(WC & HC), waist-to-hip ratio (WHR), waist-to-
height ratio (WHtR) 
Lipid profile 
Total cholesterol, HDL, LDL, triglyceride (TG) 
Fasting glucose, insulin, HOMA-IR 
DEXA whole body composition scan 
Metabolic disease states 
•  Impaired Glucose tolerance (IGT): fasting 
glucose ≥100  mg/dL  
•  Metabolic Syndrome defined as ≥ 3 of the 
following: 1. WC (>102 cm for   , >88 cm for   ); 
2. TG (≥150 mg/dl); 3. HDL (<40 mg/dl in   , <50 
mg/dl in   ); 4. hypertension (≥130/≥85 mmHg); 
5. impaired fasting glucose (≥100 mg/dl). 
Analysis: R version 3.0.1 analyzed with non-
parametric distribution. 
 
 
 
 
 
 
RESULTS 
DEXA-VAT Associations with Metabolic Risk Factors 
 
 
 
 
 
 
 
 
 
 
 
 
Overall, DEXA-VAT was positively associated with 
SBP, DBP, TG, fasting glucose & insulin, HOMA-IR, 
and negatively associated with HDL. DEXA-VAT 
was still associated with SBP, DBP, insulin, and 
HOMA-IR after adjusting for race, and associated 
with hsCRP after adjusting for the int’n with race. 
 
RESULTS 
Multivariate LASSO Regression for IGT 
 
 
 
 
 
 
 
 
 
A: combination of anthropometric, body composition, 
and cardiometabolic variables guided by previous 
binary regressions presented with adjusted odds ratios 
(OR); B: ANOVA analysis of A adjusted for race; C: 
ANOVA analysis of A adjusted for interaction with race. 
 
Multivariate LASSO Regression for MetSx 
 
 
 
 
 
 
 
 
A: combination of anthropometric, body composition, 
and cardiometabolic variables guided by previous 
binary regressions presented with adjusted odds ratios 
(OR); B: ANOVA analysis of A adjusted for race; C: 
ANOVA analysis of A adjusted for interaction with race. 
CONCLUSION 
•  DEXA-VAT was positively associated with TG, 
fasting glucose & insulin, and HOMA-IR, and 
negatively associated with HDL-C 
•  In binary regression analysis, DEXA-VAT was a 
more robust predictor of IGT and MetSx than other 
anthropometric and body composition variables 
•  In Mutivariate LASSO regression, the odds ratio for 
having IGT was most robustly predicted by HOMA-
IR and DEXA-VAT; the odds ratio for having MetSx 
was most robustly predicted by DEXA-VAT 
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Figure: Coronal DEXA image 
for a sample subject. The 
blue trapezoidal region of 
interest is used for reporting 
the DEXA trunk (abdominal) 
adipose and lean soft tissue 
masses. 
